Your Second Mounjaro Dose: What to Decide and How to Get It Right

Staying at 2.5 mg vs. moving up: who decides and on what basis

The first question most people reach week two with is a simple one: am I still on 2.5 mg, and is that normal? The answer is almost always yes, and it is by design. Tirzepatide's licenced schedule starts low to let your digestive system adjust, not because 2.5 mg is where the therapeutic work happens. Your prescriber sets the pace, weighing how you tolerated week one against the target dose for your situation.

A question our prescribers hear most weeks is some version of: "can I go up faster if I felt fine?" The honest answer is that the schedule exists precisely because tolerability in week one does not always predict how week three feels. Moving up too quickly is one of the more consistent reasons people experience avoidable nausea. The titration timeline is a clinical recommendation, not a rough guide.

When a dose increase does happen, it comes from your prescriber after a review of your progress — at nume, that review happens before every repeat order, not as an administrative checkbox but as a clinical read of where you are. The move from one Mounjaro dose to the next is covered in more depth if you want the full picture on timing and thresholds.

NHS guidance on weight-management medicines confirms that titration is the prescriber's call, not the patient's, and that the schedule described in the SmPC is the evidenced framework clinicians follow. You can read the Mounjaro summary on the NHS tirzepatide medicines page for a plain-English overview of how the doses are structured.

The injection itself: site rotation and the practical details week two onwards

Technically, the second injection is no different from the first. Same pen, same technique. What does change from here is site rotation, and it matters more than it sounds. Using the same small patch of skin repeatedly can cause fatty lumps under the skin (lipohypertrophy), which affects how well the medicine absorbs. The rule is to move to a different spot within the same body area, or switch to a different area altogether, each week.

The three licensed injection sites are the abdomen (avoiding a 5 cm radius around the navel), the thigh and the outer upper arm. Most people cycle through these, or rotate quadrants within one site. There is no clinical hierarchy among them for Mounjaro; the most practical spot is usually the right one.

On technique: the pen should be at room temperature for a few minutes before you use it, the skin should be clean, and the pen should be pressed flat against the skin and held until the injection is complete and the second click sounds. The pen is single-use. Disposal in a sharps container is the correct and legal method; household bins are not suitable for used pens.

More detail on the injection process itself, including common first-timer questions, is on the Mounjaro injection guide if you want a step-by-step walkthrough.

Side effects in week two: what's expected, what's not, and when to call for help

Nausea, loose stools, fatigue and a reduced appetite are the effects most people notice in the early weeks. For the majority they peak a day or two after the injection and ease off by the end of the week. By week four, many people find the pattern is predictable enough that they can plan around it.

What is worth knowing is that these effects can resurface mildly when a dose increases, even if week two felt fine. That is normal, and temporary. Staying well-hydrated, eating smaller meals slowly, and not injecting on an empty stomach are practical habits that tend to help.

There are symptoms that warrant prompt medical attention: severe stomach pain that spreads to the back, persistent vomiting where you cannot keep fluids down, signs of an allergic reaction (swelling, difficulty breathing, rapid heartbeat), or yellowing of the skin or eyes. These are infrequent, but they are serious. The MHRA Yellow Card scheme lets you report any suspected side effects directly, which helps regulators monitor how medicines perform in real-world use.

For a fuller breakdown of what the clinical evidence says about side effects across the treatment period, the Mounjaro treatment overview covers the evidence picture in context. And if you have a specific concern about how week two went, our aftercare team is available seven days a week.

Timing, storage and what happens if week two doesn't go to plan

Mounjaro is designed to be taken once weekly, ideally on the same day. If you inject a day early or a day late, it is not a clinical emergency, but consistency does support steadier drug levels. If you miss your injection day entirely, the general principle is to take it as soon as you remember, provided your next dose is still at least four days away. If you are closer than that to your next scheduled day, skip the missed one and carry on with the usual schedule. Our guidance on how to take your second dose of Mounjaro sets this out clearly, and your prescriber can advise on your specific situation.

Storage matters too. Mounjaro pens should be kept refrigerated at 2–8°C until you are ready to use them. If you want a reliable reference for Mounjaro second dose instructions, including the exact room-temperature window, that page draws directly on SmPC guidance rather than relying on any secondhand figure, as the guidance is specific to this medicine. You can also cross-reference the electronic Medicines Compendium (eMC) for the full SmPC detail.

If you are considering your options for ongoing treatment or want to understand how pricing works over several months, the weight-loss treatments page covers the full picture of what a private prescription includes.

When everything is straightforward, starting your second dose of Mounjaro is mostly a case of picking up where you left off. The clinical framework is already set. The prescription is already written. Your job is to inject on time, rotate your site, and keep an eye on how you feel. Check your eligibility and speak to our prescribers if anything gives you pause.